In silico study of fucoxanthin as a tumor cytotoxic agent

Journal of Pharmacy and Bioallied Sciences

Volumn 4, Issue 1, 2012, Pages 56-59

  Januar, Hedi I ^a   Dewi, Ariyanti S ^a   Marraskuranto, Endar ^a   Wikanta, Thamrin ^a  

^a Jl KS Tubun Petamburan VI   (India)

Author keywords

Autodock Vina; cytotoxic; fucoxanthin; in silico

Indexed keywords

ALANINE; COLCHICINE; CYCLIN DEPENDENT KINASE 2; FUCOXANTHIN; PACLITAXEL; PROTEIN P53; TUBULIN; VALINE; VINBLASTINE;

ALGORITHM; ARTICLE; AUTODOCK VINA ALGORITHM; CELL CYCLE ARREST; COMPUTER MODEL; CONTROLLED STUDY; CYTOTOXICITY; DEPOLIMERIZATION; DRUG BINDING SITE; DRUG MECHANISM; DRUG PROTEIN BINDING; MOLECULAR DOCKING; POLYMERIZATION; PREDICTION; PRIORITY JOURNAL;

EID: 84856836127     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.92733     Document Type: Article

References (34)

1. Hosokawa M, Miyashita T, Nishikawa S, Emi S, Tsukui T, Beppu F, et al. Fucoxanthin regulates adipocytokine mRNA expression in white adipose tissue of diabetic/obese KK-Ay mice. Arch Biochem Biophys 2010;504:17-25.
2. Kotake-Nara E, Asai A, Nagao A. Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells. Cancer Lett 2005;220:75-84. (Pubitemid 40312020)
3. Kotake-Nara E, Terasaki M, Nagao, A. Characterization of apoptosis induced by fucoxanthin in human promyelocytic leukemia cells. Biosci Biotechnol Biochem 2005;69:224-7. (Pubitemid 40383507)
4. Nakazawa Y, Sashima T, Hosokawa M, Miyashita K. Comparative evaluation of growth inhibitory effect of stereoisomers of fucoxanthin in human cancer cell lines. J Funct Foods 2009;1:88-97.
5. Fajarningsih ND, Nursid M, Wikanta T, dan Marraskuranto E. Bioactivity of Turbinaria deccurens extract as antitumor (HeLa dan T47D) and its effects to lymphocyte proliferation. Indones J Mar Fisheries Prod Process Biotechnol 2008;3:21-7.
6. Ishikawa C, Tafuku S, Kadekaru T, Sawada S, Tomita M, Okudaira T, et al. Antiadult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. Int J Cancer 2008;123:2702-12.
7. Kim KN, Heo SJ, Kang SM, Ahn G, Jeon YJ. Fucoxanthin induces apoptosis in human leukemia HL-60 cells through a ROS-mediated Bcl-xL pathway. Toxicol In Vitro 2010;24:1648-54.
8. Liu CL, Huang YS, Hosokawa M, Miyashita K, Hu ML. Inhibition of proliferation of a hepatoma cell line by fucoxanthin in relation to cell cycle arrest and enhanced gap junctional intercellular communication. Chem Biol Interact 2009;182:165-72.
9. Nursid M, Fajaningsih ND, Januar HI, Wikanta T. Apoptosis Induction and p53 Gene expression from Turbinaria deccuens to heLa tumor cells. Indones J Mar Fisheries Prod Process Biotechnol 2007;2:20-4.
10. Das SK, Takasi H, Kazuki K. Growth inhibition of human hepatic carcinoma Hep G2 cells by fucoxanthin is associated with down-regulation of Cyclin-D. Biochem Biophys Acta 2008;4:743-9.
11. Jordan MA, Wilson L. Microtubule as a target for anticancer drugs. Nat Rev 2004;4:253-65.
12. Tuma MC, Malikzay A, Ouyang X, Surguladze D, Fleming J, Mitelman S, et al. Antitumor activity of IMC-038525, a novel oral tubulin polymerization inhibitor. Transl Oncol 2010;3:318-25.
13. Villanueva HE, Setzer WN. Cembrene diterpenoids: Conformational studies and molecular docking to tubulin. Rec Nat Prod 2010;4:115-23.
14. Haïdara K, Zamir L, Shi QW, Batist G. The flavonoid casticin has multiple mechanisms of tumor cytotoxicity action. Cancer Lett 2006;242:180-90. (Pubitemid 44485312)
15. Nagal A, Jangir OP, Solanki PS, Sigh V, Krishanohan M. In silico and in vivo study of lens regeneration under influence retinoid. J Proteomics Bioinf 2008;1:104-8.
16. Brooijmans N. Docking Methods, Ligand Design, and Validating Data Sets in the Structural Genomic Era. In: Gu J, Bourne PE, editors. Structural Bioinformatics. United States: John Wiley and Sons Inc;2009. p. 635-63.
17. Trott O, Olson AJ. AutoDock vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem 2010;31:455-61.
18. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, et al. In vivo activation of the p53 pathway by small molecule antagonists of MDM2. Science 2004;303:844-8. (Pubitemid 38174664)
19. Lawrie AM, Noble ME, Tunnah P, Brown NR, Johnson IN, Endicott JA. Protein kinase inhibition by staurosporin revealed in details of the molecular interaction with CDK 2. Nat Struct Biol 1997;4:796-801.
20. Lowe J, Li H, Downing KH, Nogales E. Refined structure of alpha beta tubulin at 3.5 A resolution. J Mol Biol 2001;313:1045-57. (Pubitemid 33081900)
21. Ravelli RB, Gigant B, Curmi PA, Jourdain I, Lachkar S, Sobel A, et al. Insight into tubulin regulation from a complex with colnicine and a stathmin-like domain. Nature 2004;428:198-202. (Pubitemid 38374318)
22. Gigant B, Wang C, Ravelli RB, Roussi F, Steinmetz MO, Curmi PA, et al. Structural basis for the regulation of tubulin by vinblastin. Nature 2005;435:519-22. (Pubitemid 40734250)
23. Munro MHG, Blunt JW. MarinLit-Marine Literature Database, Version 13.5. Marine Chemistry Group, Department of Chemistry-University of Canterbury. Christchurch, New Zealand;2007.
24. Hetch D, Fogel GB. A novel in silico approach to drug discovery via computational intellegence. J Chem Info Model 2009;8:10-21.
25. Haryadi W, Jenie UA, Sudibyo RS, Pranowo HD, Wibowo FR. Molecular docking of anydroerythromycin to r-RNA 23S Deinococcus radiodurans and the prediction of its antibiotic potency. Indones J Chem 2009;9:303-7.
26. Istyastono EP. Docking studies of curcumin as a potential lead compound to develop novel dipeptydyl peptidase-4 inhibitors. Indones J Chem 2009;9:123-6.
27. Kartasasmita RE, Herowati R, Harmastuti N, Gusdinar T. Quercetion derivatives docking based on study of flavonoids interaction to cyctooxygenase-2. Indones J Chem 2009;9:297-302.
28. Prakash N, Patel S, Faldu NJ, Ranjan R, Sudheer DV. Molecular docking studies of antimalarial drugs for malaria. J Comput Sci Syst Biol 2010;3:70-3.
29. Shankaracharya, Priyamvada, Vidyarthi AS. in silico prediction of D-HSCDK2 structure and its docking study with plavopiridiol analogues. J Chem Pharm Res 2010;2:329-37.
30. Sa G, Das T. Anti cancer effects of curcumin: Cycle of life and death. Cell Div 2008;3:14.
31. Okuzumi J, Nishino H, Murakoshi M, Iwashima A, Tanaka Y, Yamane T, et al. Inhibitory effects of fucoxanthin, a natural carotenoid, on N-myc expression and cell cycle progression in human malignant tumor cells. Cancer Lett 1990;55:75-81.
32. Blajeski AL, Phan VA, Kottke TJ Kaufmann SH. G1 and G2 cell-cycle arrest following microtubule depolymerization in human breast cancer cells. J Clin Invest 2002;110:91-9. (Pubitemid 34743469)
33. Mooberry SL, Weiderhold KN, Dakshanamurthy S, Hamel E, Banner EJ, Kharlamova A, et al. Identification and characterization of a new tubulin-binding. Tetrasubstituted brominated pyrrole. Mol Pharmacol 2007;72:132-40. (Pubitemid 46998532)
34. Carre M, Andre N, Carles G, Borghi H, Brichese L, Briand C, et al. Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel. J Biol Chem 2002;277:33664-9.